NATCO PHARMA LTD - stock earnings
NATCOPHARM.NS Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 27, 2024 BeforeMarket | - / - | - | - / 5.8 billion | - |
NATCOPHARM.NS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 2.1 billion INR | 7.6 billion INR |
| 2023Q3 | 3.7 billion INR | 10.3 billion INR |
| 2023Q2 | 4.2 billion INR | 11.4 billion INR |
| 2023Q1 | 2.8 billion INR | 9.0 billion INR |
| 2022Q4 | 623.0 million INR | 4.9 billion INR |
| 2022Q3 | 568.0 million INR | 4.3 billion INR |
| 2022Q2 | 3.2 billion INR | 8.8 billion INR |
| 2022Q1 | -505.0 million INR | 5.6 billion INR |
| 2021Q4 | 804.0 million INR | 5.6 billion INR |
| 2021Q3 | 651.0 million INR | 3.8 billion INR |
| 2021Q2 | 750.0 million INR | 4.1 billion INR |
| 2021Q1 | 530.0 million INR | -305.0 million INR |
| 2020Q4 | 627.0 million INR | 3.6 billion INR |
| 2020Q3 | 2.0 billion INR | 8.0 billion INR |
| 2020Q2 | 1.2 billion INR | 5.6 billion INR |
| 2020Q1 | 941.0 million INR | 4.3 billion INR |
| 2019Q4 | 1.0 billion INR | 4.8 billion INR |
| 2019Q3 | 1.2 billion INR | 4.9 billion INR |
| 2019Q2 | 1.4 billion INR | 4.9 billion INR |
| 2019Q1 | 1.2 billion INR | 4.2 billion INR |
| 2018Q4 | 1.6 billion INR | 5.6 billion INR |
| 2018Q3 | 1.8 billion INR | 5.4 billion INR |
| 2018Q2 | 1.8 billion INR | 5.4 billion INR |
| 2018Q1 | 3.0 billion INR | 7.7 billion INR |
| 2017Q4 | 2.2 billion INR | 5.6 billion INR |
| 2017Q3 | 848.0 million INR | 4.3 billion INR |
| 2017Q2 | 937.0 million INR | 4.3 billion INR |
| 2017Q1 | 1.8 billion INR | 5.8 billion INR |
| 2016Q4 | 2.0 billion INR | 6.4 billion INR |
| 2016Q3 | 665.5 million INR | 4.2 billion INR |
| 2016Q2 | 476.5 million INR | 3.0 billion INR |
| 2016Q1 | 628.0 million INR | 3.9 billion INR |
| 2015Q4 | 371.5 million INR | 2.6 billion INR |
| 2015Q3 | 295.7 million INR | 2.2 billion INR |
| 2015Q2 | 282.3 million INR | 2.2 billion INR |
| 2015Q1 | 544.5 million INR | 2.4 billion INR |
| 2014Q4 | 143.4 million INR | 1.8 billion INR |
| 2014Q3 | 323.7 million INR | 2.1 billion INR |
| 2014Q2 | 334.6 million INR | 1.9 billion INR |
| 2014Q1 | 240.1 million INR | 2.2 billion INR |
| 2013Q4 | 298.8 million INR | 1.9 billion INR |
| 2013Q3 | 269.2 million INR | 1.6 billion INR |
| 2013Q2 | 217.8 million INR | 1.6 billion INR |
| 2013Q1 | 113.3 million INR | 1.8 billion INR |
| 2012Q4 | 225.9 million INR | 1.6 billion INR |
| 2012Q3 | 209.9 million INR | 1.8 billion INR |
| 2012Q2 | 170.7 million INR | 1.3 billion INR |
| 2012Q1 | 126.5 million INR | 1.6 billion INR |
| 2011Q4 | 170.0 million INR | 1.3 billion INR |
| 2011Q3 | 159.4 million INR | 1.3 billion INR |
NATCOPHARM.NS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 7.2 billion INR | 27.1 billion INR |
| 2022 | 1.7 billion INR | 19.0 billion INR |
| 2021 | 4.4 billion INR | 16.9 billion INR |
| 2020 | 4.6 billion INR | 18.9 billion INR |
| 2019 | 6.4 billion INR | 20.6 billion INR |
| 2018 | 7.0 billion INR | 21.6 billion INR |
| 2017 | 4.9 billion INR | 20.4 billion INR |
| 2016 | 1.6 billion INR | 11.2 billion INR |
| 2015 | 1.3 billion INR | 8.2 billion INR |
| 2014 | 1.0 billion INR | 7.3 billion INR |
| 2013 | 718.7 million INR | 6.5 billion INR |
| 2012 | 596.1 million INR | 5.2 billion INR |
| 2011 | 535.1 million INR | 4.4 billion INR |
| 2010 | 487.2 million INR | 4.3 billion INR |
| 2009 | 439.7 million INR | 4.4 billion INR |
| 2008 | 405.1 million INR | 3.3 billion INR |
| 2007 | 304.6 million INR | 2.4 billion INR |
| 2006 | 237.9 million INR | 1.7 billion INR |
| 2005 | 15.6 million INR | 1.5 billion INR |
NATCOPHARM.NS
Price: ₹995.10
Dividend Yield: 0.01%
Forward Dividend Yield: 0.25%
Payout Ratio: 3.53%
Dividend Per Share: 2.50 INR
Earnings Per Share: 70.92 INR
P/E Ratio: 13.47
Exchange: NSI
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 173.7 billion
Average Dividend Frequency: 2
Years Paying Dividends: 15
DGR3: 23.52%
DGR5: 13.11%
DGR10: 30.00%